Citations (63)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (10)
Sandra Prior, Simon E. Hufton, Bernard Fox, Thomas Dougall, Peter Rigsby & Adrian Bristow. (2018) International standards for monoclonal antibodies to support pre- and post-marketing product consistency: Evaluation of a candidate international standard for the bioactivities of rituximab. mAbs 10:1, pages 129-142.
Read now
Read now
Xiaoyu Yang, Wei Xu, Svetlana Dukleska, Sabrina Benchaar, Selina Mengisen, Valentyn Antochshuk, Jason Cheung, Leslie Mann, Zulfia Babadjanova, Jason Rowand, Rico Gunawan, Alexander McCampbell, Maribel Beaumont, David Meininger, Daisy Richardson & Alexandre Ambrogelly. (2013) Developability studies before initiation of process development. mAbs 5:5, pages 787-794.
Read now
Read now
Hugo M Vargas, Hamid R Amouzadeh & Michael J Engwall. (2013) Nonclinical strategy considerations for safety pharmacology: evaluation of biopharmaceuticals. Expert Opinion on Drug Safety 12:1, pages 91-102.
Read now
Read now
Petrus J. Pauwels, Charles Dumontet, Janice M. Reichert, Alain Beck, Liliane Goetsch, Nathalie Corvaïa, Christian Klein, Bertrand Coiffier & Beverly A. Teicher. (2012) 7th Cancer Scientific Forum of the Cancéropôle Lyon Auvergne Rhône-Alpes. mAbs 4:4, pages 434-444.
Read now
Read now
Reema Piparia, David Ouellette, W. Blaine Stine, Christine Grinnell, Edit Tarcsa, Czeslaw Radziejewski & Ivan Correia. (2012) A high throughput capillary electrophoresis method to obtain pharmacokinetics and quality attributes of a therapeutic molecule in circulation. mAbs 4:4, pages 521-531.
Read now
Read now
Christian Votsmeier, Hanna Plittersdorf, Oliver Hesse, Andreas Scheidig, Michael Strerath, Uwe Gritzan, Klaus Pellengahr, Peter Scholz, Andrea Eicker, David Myszka, Wayne M. Coco & Ulrich Haupts. (2012) Femtomolar Fab binding affinities to a protein target by alternative CDR residue co-optimization strategies without phage or cell surface display. mAbs 4:3, pages 341-348.
Read now
Read now
Randall J. Brezski, Allison Oberholtzer, Brandy Strake & Robert E. Jordan. (2011) The in vitro resistance of IgG2 to proteolytic attack concurs with a comparative paucity of autoantibodies against peptide analogs of the IgG2 hinge. mAbs 3:6, pages 558-567.
Read now
Read now
Shanmuuga Sundaram, Alice Matathia, Jun Qian, Jingming Zhang, Ming-Ching Hsieh, Tun Liu, Richard Crowley, Babita Parekh & Qinwei Zhou. (2011) An innovative approach for the characterization of the isoforms of a monoclonal antibody product. mAbs 3:6, pages 505-512.
Read now
Read now
Trent P. Munro, Stephen M. Mahler, Edwin P. Huang, David Y. Chin & Peter P. Gray. (2011) Bridging the gap. mAbs 3:5, pages 440-452.
Read now
Read now
Janice M. Reichert. (2011)
Antibody-based therapeutics to watch in 2011
. mAbs 3:1, pages 76-99.
Read now
Read now
Articles from other publishers (53)
Traian Sulea, Christophe Deprez, Christopher R. Corbeil & Enrico O. Purisima. 2023. Computer-Aided Antibody Design. Computer-Aided Antibody Design
361
374
.
Yuichiro Takamatsu, Takao Hamakubo & Takefumi Yamashita. (2022) Molecular Dynamics Simulation of the Antigen–Antibody Complex Formation Process between Hen Egg-White Lysozyme and HyHEL-10. Bulletin of the Chemical Society of Japan 95:11, pages 1611-1619.
Crossref
Crossref
Eri Takematsu, Miles Massidda, Jeff Auster, Po-Chih Chen, ByungGee Im, Sanjana Srinath, Sophia Canga, Aditya Singh, Marjan Majid, Michael Sherman, Andrew Dunn, Annette Graham, Patricia Martin & Aaron B. Baker. (2022) Transmembrane stem cell factor protein therapeutics enhance revascularization in ischemia without mast cell activation. Nature Communications 13:1.
Crossref
Crossref
Andy C. Tran, Gil R. Diogo, Matthew J. Paul, Alastair Copland, Peter Hart, Nickita Mehta, Edward. B. Irvine, Tufária Mussá, Pascal M. W. Drake, Juraj Ivanyi, Galit Alter & Rajko Reljic. (2020) Mucosal Therapy of Multi-Drug Resistant Tuberculosis With IgA and Interferon-γ. Frontiers in Immunology 11.
Crossref
Crossref
Cecilie Knudsen, Line Ledsgaard, Rasmus Ibsen Dehli, Shirin Ahmadi, Christoffer Vinther Sørensen & Andreas Hougaard Laustsen. (2019) Engineering and design considerations for next-generation snakebite antivenoms. Toxicon 167, pages 67-75.
Crossref
Crossref
Sepideh Jalilzadeh-Razin, Malihe Mantegi, Mohammad R. Tohidkia, Yaghub Pazhang, Mohammad M. Pourseif, Jaleh Barar & Yadollah Omidi. (2019) Phage antibody library screening for the selection of novel high-affinity human single-chain variable fragment against gastrin receptor: an in silico and in vitro study. DARU Journal of Pharmaceutical Sciences 27:1, pages 21-34.
Crossref
Crossref
Ashley R. Sutherland, Md. Kausar Alam & C. Ronald Geyer. (2018) Post‐translational Assembly of Protein Parts into Complex Devices by Using SpyTag/SpyCatcher Protein Ligase. ChemBioChem 20:3, pages 319-328.
Crossref
Crossref
Wei Zhou, Shanshan Lin, Rongying Chen, Jun Liu & Yali Li. (2018) Characterization of antibody-C1q interactions by Biolayer Interferometry. Analytical Biochemistry 549, pages 143-148.
Crossref
Crossref
Florian Cymer, Hermann Beck, Adelheid Rohde & Dietmar Reusch. (2018) Therapeutic monoclonal antibody N-glycosylation – Structure, function and therapeutic potential. Biologicals 52, pages 1-11.
Crossref
Crossref
Traian Sulea, Greg Hussack, Shannon Ryan, Jamshid Tanha & Enrico O. Purisima. (2018) Application of Assisted Design of Antibody and Protein Therapeutics (ADAPT) improves efficacy of a Clostridium difficile toxin A single-domain antibody. Scientific Reports 8:1.
Crossref
Crossref
Yujie Yang, Tommy R. Li & Joseph P. Balthasar. (2017) Investigation of the Influence of Protein-Losing Enteropathy on Monoclonal Antibody Pharmacokinetics in Mice. The AAPS Journal 19:6, pages 1791-1803.
Crossref
Crossref
Abhinav A. Shukla, Leslie S. Wolfe, Sigma S. Mostafa & Carnley Norman. (2017) Evolving trends in mAb production processes. Bioengineering & Translational Medicine 2:1, pages 58-69.
Crossref
Crossref
Ambrose J. Williams, Robert D. Ovadia & Glen S. Giese. (2017)
Improving Stepwise Assembly of a Bispecific F(ab′)
2
from Two Different Fab′ Molecules
. Industrial & Engineering Chemistry Research 56:7, pages 1713-1722.
Crossref
Crossref
Anil K. Sharma, Raj K. Keservani & Rajesh K. Kesharwani. 2017. Novel Approaches for Drug Delivery. Novel Approaches for Drug Delivery
171
188
.
L.M. Alvarenga, J. de Moura & P. Billiald. 2017. Current Developments in Biotechnology and Bioengineering. Current Developments in Biotechnology and Bioengineering
97
121
.
A.A. Shukla, L. Wolfe & C. Norman. 2017. Comprehensive Medicinal Chemistry III. Comprehensive Medicinal Chemistry III
171
179
.
Yuchen Pan, Eric K. Sackmann, Karolina Wypisniak, Michael Hornsby, Sammy S. Datwani & Amy E. Herr. (2016) Determination of equilibrium dissociation constants for recombinant antibodies by high-throughput affinity electrophoresis. Scientific Reports 6:1.
Crossref
Crossref
Traian Sulea, Victor Vivcharuk, Christopher R. Corbeil, Christophe Deprez & Enrico O. Purisima. (2016) Assessment of Solvated Interaction Energy Function for Ranking Antibody–Antigen Binding Affinities. Journal of Chemical Information and Modeling 56:7, pages 1292-1303.
Crossref
Crossref
Chantal Kuhn & Howard L Weiner. (2016) Therapeutic anti-CD3 monoclonal antibodies: from bench to bedside. Immunotherapy 8:8, pages 889-906.
Crossref
Crossref
Joseph J. Priola, Nathan Calzadilla, Martina Baumann, Nicole Borth, Christopher G. Tate & Michael J. Betenbaugh. (2016) High-throughput screening and selection of mammalian cells for enhanced protein production. Biotechnology Journal 11:7, pages 853-865.
Crossref
Crossref
M.N. McCracken, R. Tavaré, O.N. Witte & A.M. Wu. 2016.
187
231
.
Theresa Yuraszeck & Megan Gibbs. 2010. Pharmaceutical Sciences Encyclopedia. Pharmaceutical Sciences Encyclopedia
1
15
.
Gregory Keil. (2015) High-throughput screening and automation approaches for the development of recombinant therapeutic proteins. Pharmaceutical Bioprocessing 3:5, pages 371-380.
Crossref
Crossref
Ambrose Jon Williams, Glen Giese & Josefine Persson. (2015) Improved assembly of bispecific antibodies from knob and hole half-antibodies. Biotechnology Progress 31:5, pages 1315-1322.
Crossref
Crossref
Qiang Wu, Ho Young Lee, Pin Yee Wong, Guoying Jiang & Hélène Gazzano-Santoro. (2015) Development and applications of AlphaScreen-based FcRn binding assay to characterize monoclonal antibodies. Journal of Immunological Methods 420, pages 31-37.
Crossref
Crossref
Joshua D Jones. (2015) Leishmania tarentolae: an alternative approach to the production of monoclonal antibodies to treat emerging viral infections. Infectious Diseases of Poverty 4:1, pages 8.
Crossref
Crossref
Amita Datta-Mannan & Victor J. Wroblewski. (2014) Application of FcRn Binding Assays to Guide mAb Development. Drug Metabolism and Disposition 42:11, pages 1867-1872.
Crossref
Crossref
Jeff Jia Cheng Hou, Ben S. Hughes, Matthew Smede, Kar Man Leung, Kara Levine, Susan Rigby, Peter P. Gray & Trent P. Munro. (2014) High-throughput ClonePix FL analysis of mAb-expressing clones using the UCOE expression system. New Biotechnology 31:3, pages 214-220.
Crossref
Crossref
Frank A. Engler, Bo Zheng & Joseph P. Balthasar. (2013) Investigation of the Influence of Nephropathy on Monoclonal Antibody Disposition: A Pharmacokinetic Study in a Mouse Model of Diabetic Nephropathy. Pharmaceutical Research 31:5, pages 1185-1193.
Crossref
Crossref
Philip W. Addis, Catherine J. Hall, Shaun Bruton, Vaclav Veverka, Ian C. Wilkinson, Frederick W. Muskett, Philip S. Renshaw, Christine E. Prosser, Bruce Carrington, Alastair D.G. Lawson, Robert Griffin, Richard J. Taylor, Lorna C. Waters, Alistair J. Henry & Mark D. Carr. (2014) Conformational Heterogeneity in Antibody-Protein Antigen Recognition. Journal of Biological Chemistry 289:10, pages 7200-7210.
Crossref
Crossref
Antonio Gualberto. 2015. Molecular Oncology. Molecular Oncology
854
860
.
Michelle Kinder, Allison R. Greenplate, Katharine D. Grugan, Keri L. Soring, Katharine A. Heeringa, Stephen G. McCarthy, Gregory Bannish, Meredith Perpetua, Frank Lynch, Robert E. Jordan, William R. Strohl & Randall J. Brezski. (2013) Engineered Protease-resistant Antibodies with Selectable Cell-killing Functions. Journal of Biological Chemistry 288:43, pages 30843-30854.
Crossref
Crossref
Boris Gala-Lopez, Andrew R. Pepper & A. M. James Shapiro. (2013) Biologic Agents in Islet Transplantation. Current Diabetes Reports 13:5, pages 713-722.
Crossref
Crossref
Sumit Goswami, Wei Wang, Tsutomu Arakawa & Satoshi Ohtake. (2013) Developments and Challenges for mAb-Based Therapeutics. Antibodies 2:4, pages 452-500.
Crossref
Crossref
Anjaneya P. Chimalakonda, Rajbharan Yadav & Punit Marathe. (2013) Factors Influencing Magnitude and Duration of Target Inhibition Following Antibody Therapy: Implications in Drug Discovery and Development. The AAPS Journal 15:3, pages 717-727.
Crossref
Crossref
Trent P Munro. (2013) Biologics 2.0: can ‘omics technology improve mammalian cell-based manufacturing?. Pharmaceutical Bioprocessing 1:1, pages 11-13.
Crossref
Crossref
B. J. Tillotson, I. F. de Larrinoa, C. A. Skinner, D. M. Klavas & E. V. Shusta. (2012) Antibody affinity maturation using yeast display with detergent-solubilized membrane proteins as antigen sources. Protein Engineering Design and Selection 26:2, pages 101-112.
Crossref
Crossref
Bo Wang, Ashley C. Gucinski, David A. Keire, Lucinda F. Buhse & Michael T. Boyne II. (2013) Structural comparison of two anti-CD20 monoclonal antibody drug products using middle-down mass spectrometry. The Analyst 138:10, pages 3058.
Crossref
Crossref
Katharine D. Grugan, Francis L. McCabe, Michelle Kinder, Allison R. Greenplate, Benjamin C. Harman, Jason E. Ekert, Nico van Rooijen, G. Mark Anderson, Jeffrey A. Nemeth, William R. Strohl, Robert E. Jordan & Randall J. Brezski. (2012) Tumor-Associated Macrophages Promote Invasion while Retaining Fc-Dependent Anti-Tumor Function. The Journal of Immunology 189:11, pages 5457-5466.
Crossref
Crossref
Dana Litvak-Greenfeld & Itai Benhar. (2012) Risks and untoward toxicities of antibody-based immunoconjugates. Advanced Drug Delivery Reviews 64:15, pages 1782-1799.
Crossref
Crossref
Rashmi Kshirsagar, Kyle McElearney, Alan Gilbert, Marty Sinacore & Thomas Ryll. (2012) Controlling trisulfide modification in recombinant monoclonal antibody produced in fed-batch cell culture. Biotechnology and Bioengineering 109:10, pages 2523-2532.
Crossref
Crossref
Eugenia K. Page, Wasim A. Dar & Stuart J. Knechtle. (2012) Biologics in organ transplantation. Transplant International 25:7, pages 707-719.
Crossref
Crossref
Tianlei Ying, Weizao Chen, Rui Gong, Yang Feng & Dimiter S. Dimitrov. (2012) Soluble Monomeric IgG1 Fc. Journal of Biological Chemistry 287:23, pages 19399-19408.
Crossref
Crossref
Mark J. Adler & Dimiter S. Dimitrov. (2012) Therapeutic Antibodies Against Cancer. Hematology/Oncology Clinics of North America 26:3, pages 447-481.
Crossref
Crossref
Robert M. Sharkey, Chien-Hsing Chang, Edmund A. Rossi, William J. McBride & David M. Goldenberg. (2012) Pretargeting: taking an alternate route for localizing radionuclides. Tumor Biology 33:3, pages 591-600.
Crossref
Crossref
. 2012. Therapeutic Antibody Engineering. Therapeutic Antibody Engineering
15
595
.
. 2012. Therapeutic Antibody Engineering. Therapeutic Antibody Engineering
459
595
.
Dimiter S. Dimitrov. 2012. Therapeutic Proteins. Therapeutic Proteins
1
26
.
Gary L. Gilliland, Jinquan Luo, Omid Vafa & Juan Carlos Almagro. 2012. Structure-Based Drug Discovery. Structure-Based Drug Discovery
321
349
.
Randall J. Brezski & Juan Carlos Almagro. 2012. Development of Antibody-Based Therapeutics. Development of Antibody-Based Therapeutics
65
93
.
Juan C. Almagro, Mary Pat Beavers, Francisco Hernandez-Guzman, Johannes Maier, Jodi Shaulsky, Kenneth Butenhof, Paul Labute, Nels Thorsteinson, Kenneth Kelly, Alexey Teplyakov, Jinquan Luo, Raymond Sweet & Gary L. Gilliland. (2011) Antibody modeling assessment. Proteins: Structure, Function, and Bioinformatics 79:11, pages 3050-3066.
Crossref
Crossref
Stephen Mahler & Peter GrayDirectorDirector. (2011) Biologics and the emergence of biosimilars: innovation driving global opportunity. Journal of Chemical Technology & Biotechnology 86:7, pages 893-894.
Crossref
Crossref
Paul J. Carter. (2011) Introduction to current and future protein therapeutics: A protein engineering perspective. Experimental Cell Research 317:9, pages 1261-1269.
Crossref
Crossref